1913 studies found for:    Lipid Storage Diseases
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Condition: Neutral Lipid Storage Disease
Intervention: Drug: Fibrate treatment
2 Unknown  Genetic Origin of Lipid Disorders
Condition: Lipid Disorder
Intervention:
3 Completed
Has Results
Lipid Infusion in Dialysis Patients With Endotoxemia
Conditions: Fatigue;   End Stage Renal Disease (ESRD)
Interventions: Drug: Lipidose;   Drug: Placebo
4 Recruiting Biomarker for Gaucher Disease
Conditions: Lysosomal Storage Diseases;   Gaucher Disease;   Sphingolipidoses
Intervention:
5 Recruiting Natural History Study of Children With Metachromatic Leukodystrophy
Conditions: Leukodystrophy, Metachromatic;   Hereditary Central Nervous System Demyelinating Diseases;   Brain Diseases, Metabolic, Inborn;   Brain Diseases, Metabolic;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Sulfatidosis;   Sphingolipidoses;   Lysosomal Storage Diseases, Nervous System;   Leukoencephalopathies;   Demyelinating Diseases;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Lipidoses;   Lipid Metabolism, Inborn Errors;   Lysosomal Storage Diseases;   Metabolic Diseases;   Lipid Metabolism Disorders
Intervention: Other: Natural History Study of Children With Metachromatic Leukodystrophy
6 Recruiting A Mediterranean-style Breakfast and Postprandial Lipid Disorders in Obese Pre-adolescents and Adults
Condition: Obesity
Interventions: Dietary Supplement: Mediterranean-style breakfast;   Dietary Supplement: Western-style breakfast
7 Active, not recruiting A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers
Conditions: Obesity;   Lipid Disorders
Interventions: Drug: ZYT1;   Drug: Placebo tablets
8 Completed
Has Results
Lipid Management in Clinical Practice (MK-0524A-115)
Condition: Lipid Metabolism Disorder
Intervention:
9 Active, not recruiting Physical Activity and Nutrition in Children Study
Conditions: Overweight;   Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Blood Pressure;   Fitness
Intervention: Behavioral: lifestyle counseling
10 Terminated
Has Results
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Conditions: Hurler's Syndrome;   Maroteaux-Lamy Syndrome;   Sly Syndrome;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Sphingolipidoses;   Krabbe Disease;   Wolman's Disease;   Niemann-Pick Disease Type B;   Niemann-Pick Disease, Type C
Interventions: Procedure: Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Campath-1H;   Drug: Busulfan
11 Recruiting MT2013-31:Allo BMT for Metabolic Disorders, Osteopetrosis and Males With Rett Syndrome
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Rett Syndrome;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid
12 Completed Pharmacological Regulation of Fat Transport in Metabolic Syndrome
Conditions: Obesity;   Lipid Disorders;   Hypertriglyceridemia;   Cardiovascular Disease
Intervention: Drug: Atorvastatin and fenofibrate
13 Enrolling by invitation The Very Large Database of Lipids (VLDL)
Condition: Lipid Disorders and Lipid Measurement
Intervention:
14 Recruiting Causes and Natural History of Dyslipidemias
Condition: Dyslipidemias
Intervention:
15 Recruiting Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
Conditions: Obesity;   Disorder of Lipid Storage and Metabolism;   Lipid Metabolism Disorders;   Metabolic Disorder
Intervention: Behavioral: Exercise
16 Recruiting Biomarker for Metachromatic Leukodystrophy Disease
Conditions: Leukodystrophy, Metachromatic;   Hereditary Central Nervous System Demyelinating Diseases;   Brain Diseases, Metabolic, Inborn;   Sphingolipidoses;   Lysosomal Storage Diseases, Nervous System
Intervention:
17 Recruiting Effect of Age on Glucose and Lipid Metabolism
Conditions: Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Metabolic Diseases
Intervention: Behavioral: Aerobic Exercise
18 Recruiting Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Conditions: Familial Hypercholesterolemia;   Lipid Disorder
Intervention:
19 Completed
Has Results
Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Condition: Lipid Metabolism Disorders
Intervention: Drug: Fluvastatin sodium
20 Completed Omega 3 in Intervention Spinal Cord Injured People
Conditions: Lipid Metabolism Disorders;   Peroxidase; Defect
Interventions: Dietary Supplement: w3 supplement in SCI;   Other: placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years